GHRP-2 10 mg

GHRP-2 10 mg — a benchmark growth hormone secretagogue for endocrine research.
GHRP-2 is one of the most widely referenced synthetic growth hormone-releasing Peptides in the laboratory literature. Researchers turn to it when they need a well-characterised, reproducible tool for probing the somatotropic axis. Supplied as a lyophilised 10 mg vial, batch-tested and sealed for laboratory use.

What is GHRP-2?

GHRP-2 (growth hormone-releasing peptide 2, also catalogued as pralmorelin) is a short synthetic hexapeptide belonging to the growth hormone secretagogue class. Unlike GHRH analogues, which act at the GHRH receptor, secretagogues of this family are studied for their interaction with the growth hormone secretagogue receptor — the same receptor population engaged by the endogenous peptide ghrelin. Its compact sequence, synthetic stability and strong characterisation in the published record make it a common reference compound when investigators need a positive control or a comparator against newer secretagogue candidates.

Research interest

• Somatotropic axis signalling — investigated in models examining how pulsatile growth hormone release is initiated and regulated at the pituitary Level.
• GHS-R pharmacology — used in receptor-binding and receptor-occupancy work exploring the ghrelin receptor system.
• Comparative secretagogue studies — frequently employed as a reference peptide alongside GHRP-6, hexarelin and GHRH analogues.
• Endocrine feedback research — of interest to researchers examining interactions between secretagogue signalling and downstream hormonal mediators.
• Assay development — applied in the validation of immunoassays and analytical methods targeting peptide secretagogues.

Specifications

• Content: 10 mg of active substance per vial
• Form: Lyophilised powder (sealed vial)
• Purity: Pharmaceutical-grade, batch-tested
• Storage: Sealed and lyophilised at 2–8 °C; long-term at −20 °C, protected from light and moisture

Handling & storage

Short peptides of this class are hygroscopic and degrade fastest when moisture, heat and light are allowed to reach the cake. Keep the vial sealed and refrigerated on arrival, and allow it to equilibrate to room temperature before the stopper is broken so that condensation does not form on the powder. Reconstitution in the laboratory should follow the receiving facility's own validated protocol; solvent should be introduced gently down the vial wall rather than directly onto the cake, and the vial swirled rather than shaken to avoid shear-induced aggregation. Reconstituted material is markedly less stable than the dry form and should be held cold, protected from light and used within the working window established by the laboratory. Avoid repeated freeze–thaw cycling; aliquot instead.

Why source from Rogue

• Verified purity — every batch is traceable, analytically tested and released against its own certificate.
• European supply chain — sealed, authentic vials, shipped from within the EU and never sourced grey-market.
• Discreet, tracked delivery — fast dispatch across Europe in protective packaging, tracked end to end.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only.